U.S. Industrials Stock News

NasdaqGS:ONB
NasdaqGS:ONBBanks

Old National Bancorp (ONB) EPS Print Reinforces Bullish Earnings Growth Narrative

Old National Bancorp (ONB) opened 2026 with Q1 revenue of US$652.9 million and basic EPS of US$0.60, while trailing 12 month revenue and EPS came in at US$2.5 billion and US$1.95 respectively as the bank continued to convert its top line into earnings. Over recent quarters, revenue has ranged from US$446.6 million in Q1 2025 to US$671.3 million in Q3 2025, with basic EPS moving between US$0.34 and US$0.60 across the same period. This gives investors a clear read on how earnings track...
NYSE:LEA
NYSE:LEAAuto Components

Is It Time To Reassess Lear (LEA) After Its Strong 1 Year Share Price Jump?

If you are wondering whether Lear's current share price still offers value, it helps to start with how the market has been treating the stock recently and what that might imply for expectations baked into the price. Lear last closed at US$128.07, with returns of 7.8% over the past week, 7.7% over the past month, 8.0% year to date, 60.8% over 1 year, 5.9% over 3 years and a 26.3% decline over 5 years, which gives you a mixed picture of recent momentum and longer term sentiment. Recent company...
NYSE:CYH
NYSE:CYHHealthcare

Community Health Systems Q1 Loss Revives Bearish Narratives Around Earnings Volatility

Community Health Systems (CYH) opened 2026 with Q1 revenue of US$2.97b and a basic EPS loss of US$0.43, as net income excluding extra items came in at a loss of US$58m. The company has seen recent quarterly revenue move from US$3.27b in Q4 2024 to US$3.13b in Q2 2025, US$3.09b in Q3 2025, US$3.11b in Q4 2025 and then US$2.97b in Q1 2026. Basic EPS has ranged from a loss of US$0.53 in Q4 2024 to a peak of US$2.11 in Q2 2025 before swinging back into a loss this quarter. For investors, the mix...
NYSE:DOV
NYSE:DOVMachinery

Is It Too Late To Consider Dover (DOV) After A 31% One Year Rally

Investors may be wondering if Dover at around US$216 a share still offers value, or if most of the upside is already reflected in the price. The stock has returned 0.3% over the last week, 1.8% over the past month, 10.4% year to date and 31.4% over the past year, which puts recent moves into focus for anyone thinking about entry or exit points. Recent coverage of Dover has centered on its role in the broader capital goods space and how investors are treating established industrial names...
NYSE:GD
NYSE:GDAerospace & Defense

Is It Time To Revisit General Dynamics (GD) After The Recent Share Price Pullback?

Wondering if General Dynamics at around US$320 per share is still offering value, or if the easy gains are already behind it. The stock has pulled back with a 5.4% decline over the last 7 days and a 7.7% decline over the last 30 days, even though the 1 year return sits at 22.9% and the 5 year return at 92.7%. Recent coverage has focused on General Dynamics as a core player in US defense and aerospace, with attention on its major platforms and long term government contracts. These themes help...
NYSE:NLY
NYSE:NLYMortgage REITs

A Look At Annaly Capital Management (NLY) Valuation After Mixed Total Returns And Modest Undervaluation Estimate

Annaly Capital Management: What Recent Returns Suggest About Investor Focus Annaly Capital Management (NLY) has quietly put together a mixed return profile, with a roughly 6.6% gain over the past month, a 5.2% decline over the past 3 months, and a 38.8% total return over the past year. Alongside that share performance, Annaly reports revenue of about US$2.50b and net income of roughly US$2.02b, with both revenue and earnings showing annual growth based on the latest figures available to...
NasdaqGS:PEGA
NasdaqGS:PEGASoftware

Pegasystems (PEGA) Margin Expansion To 20% Tests Cautious Growth Narratives

Pegasystems (PEGA) opened Q1 2026 with revenue of US$430 million and basic EPS of US$0.19, against a backdrop of reported 73.2% earnings growth over the last twelve months and a trailing net profit margin of 20% compared with 12% in the prior year. Over recent quarters the company has seen revenue move from US$476 million in Q1 2025 to US$504 million in Q4 2025 and EPS range from US$0.18 to US$1.38, feeding into trailing twelve month EPS of US$2.00 on revenue of about US$1.7 billion. For...
NYSE:BMY
NYSE:BMYPharmaceuticals

Bristol Myers Squibb Aligns MTAP Precision Oncology Push With Solar Shift

Bristol Myers Squibb (NYSE:BMY) has expanded its collaboration with Foundation Medicine to develop a next generation sequencing companion diagnostic to identify patients with homozygous MTAP deletion. The company has also agreed to source 145 MW of solar power from Geronimo Power's 270 MW Blevins Solar Project as part of a long term sustainability initiative. Bristol Myers Squibb, recently trading around $58.8, has drawn fresh attention with these twin moves in precision oncology and...
NYSE:EDU
NYSE:EDUConsumer Services

New Oriental Education NYSE EDU Q3 Net Margin Compression Tests Bullish Efficiency Narrative

New Oriental Education & Technology Group (EDU) has reported a busy Q3 2026, with revenue of US$1.4b and basic EPS of US$0.80, as investors weigh these quarterly figures against a trailing twelve month EPS of US$2.65 on revenue of US$5.4b. Over recent quarters the company has seen revenue move from US$1.0b in Q2 2025 to US$1.4b in Q3 2026, while basic EPS has ranged from US$0.20 to US$1.52 across that stretch. This release is another checkpoint on how consistently the company can convert its...
NYSEAM:BHB
NYSEAM:BHBBanks

Bar Harbor Bankshares (BHB) Non‑Performing Loans Surge Tests Bullish Earnings Growth Narrative

Bar Harbor Bankshares (BHB) opened 2026 with Q1 revenue of US$46.8 million and basic EPS of US$0.81, backed by net income of US$13.5 million as the bank continued to generate earnings on a loan book of about US$3.6 billion. Over recent quarters, revenue has ranged from US$34.0 million to US$48.2 million, while basic EPS has moved between roughly US$0.40 and US$0.81. This gives investors a clearer view of how the income statement responds to shifts in activity and funding costs. With a...
NYSE:MHO
NYSE:MHOConsumer Durables

M/I Homes (MHO) Margin Compression To 8.2% Tests Bullish Earnings Narrative

M/I Homes (MHO) opened Q1 2026 with total revenue of US$920.7 million and basic EPS of US$2.61, alongside net income of US$67.8 million, setting the stage against a backdrop of moderating profitability. Over recent quarters the company has seen revenue move from US$976.1 million in Q1 2025 to US$1.2 billion in Q4 2024 and EPS range between US$2.44 and US$4.85, giving investors a clearer view of how the latest print fits into a broader earnings cycle. With trailing net profit margins at 8.2%...
NYSE:BBT
NYSE:BBTBanks

A Look At Beacon Financial (BBT) Valuation As Recent Returns Prompt Fresh Reassessment

Beacon Financial (BBT) has drawn attention after recent trading, with the share price at US$31.27 and returns mixed in the short term but positive over the past month and past 3 months. Investors are reassessing its valuation. See our latest analysis for Beacon Financial. Beacon Financial’s recent pullback, with a 1 day share price return of 0.45% and 7 day share price return of 1.01%, comes after stronger momentum, including an 18.45% year to date share price return and 31.67% total...
NYSE:TGT
NYSE:TGTConsumer Retailing

Is It Time To Reconsider Target (TGT) After A 48% One Year Share Price Gain

If you are wondering whether Target's current share price lines up with its underlying worth, the recent numbers give you plenty to think about. The stock last closed at US$130.60, with returns of 6.3% over the past week, 13.6% over the past month, 29.9% year to date and 48.2% over the last year, while the 3 year and 5 year returns sit at 6.4% and 26.1% declines respectively. These mixed return figures have arrived alongside ongoing attention on how Target is positioning itself within...
NYSE:TEVA
NYSE:TEVAPharmaceuticals

Is It Too Late To Reassess Teva (TEVA) After Its 118.5% One-Year Surge?

If you are wondering whether Teva Pharmaceutical Industries at about US$31.22 is still reasonably priced after its strong run, the next sections walk through what the current market price may be implying. The stock has returned 8.5% over the last 30 days and 118.5% over the last year, while year to date the move sits at 0.9% and the 7 day return is a 1.2% decline. Recent news flow around Teva has focused on its position in the broader pharmaceuticals sector and ongoing investor interest in...
NYSE:BRK.A
NYSE:BRK.ADiversified Financial

Berkshire Hathaway Expands In Japan With Tokio Marine Stake And Valuation Upside

Berkshire Hathaway has invested $1.8 billion to acquire a 2.49% stake in Tokio Marine Holdings. The agreement includes an option for Berkshire to increase its stake to up to 9.9% over time. The move deepens Berkshire's involvement in Japan's insurance industry through both primary insurance and potential reinsurance ties. The partnership also opens the door to joint M&A pursuits in the insurance sector. With NYSE:BRK.A recently trading around $702,980, Berkshire Hathaway is extending its...
NYSE:TFIN
NYSE:TFINBanks

Triumph Financial (TFIN) Margin Rebound Tests Justification For Premium P/E Multiple

Triumph Financial (TFIN) kicked off Q1 2026 with total revenue of US$106.4 million and basic EPS of US$0.23, set against trailing twelve month revenue of US$442.0 million and basic EPS of US$1.23. This came alongside a higher net profit margin of 6.4% compared with 2.2% in the prior year. Over recent quarters, revenue has moved from US$99.1 million in Q4 2024 to US$100.2 million in Q1 2025, US$108.8 million in Q2 2025, US$105.0 million in Q3 2025, US$121.8 million in Q4 2025, and now US$106.4...
NasdaqGM:AXSM
NasdaqGM:AXSMPharmaceuticals

Assessing Axsome Therapeutics (AXSM) Valuation As FDA Weighs Auvelity Label Expansion For Alzheimer’s Agitation

FDA decision on Auvelity label expansion puts Axsome Therapeutics (AXSM) in focus Axsome Therapeutics (AXSM) is drawing attention as investors watch for a US FDA decision on whether to expand Auvelity’s label to include agitation in Alzheimer’s disease, under a priority review process. See our latest analysis for Axsome Therapeutics. At a share price of $186.42, Axsome’s 18.86% 1 month share price return and 4.33% year to date share price return contrast with a flat 90 day move. A 78.85% 1...
NYSE:FCN
NYSE:FCNProfessional Services

A Look At FTI Consulting (FCN) Valuation After Recent Share Price Moves

FTI Consulting stock moves alongside recent return profile With no single headline event setting the tone, FTI Consulting (FCN) has drawn attention as investors weigh its recent share moves, including a 1 day decline and gains over the week, month and past 3 months. See our latest analysis for FTI Consulting. At a share price of $185.32, FTI Consulting sits on an 8.83% year to date share price return and a 9.98% 1 year total shareholder return, while the 3 year total shareholder return of a...
NYSE:RTX
NYSE:RTXAerospace & Defense

RTX (RTX) Is Down 8.8% After Raising 2026 Outlook On Record Backlog And Defense Investments – Has The Bull Case Changed?

In the past week, RTX Corporation reported first-quarter 2026 results showing sales rising to US$22.08 billion and net income reaching US$2.06 billion, with both basic and diluted EPS from continuing operations increasing year on year. Alongside these results, RTX raised its full-year outlook on the back of double-digit organic growth and a record US$271.00 billion backlog, while continuing to invest heavily in new defense technologies such as the RAIVEN Staring EO/IR sensor suite and...
NasdaqGS:HWC
NasdaqGS:HWCBanks

Hancock Whitney (HWC) Margin Compression Reinforces Skeptical Earnings Narratives In Q1 2026

Hancock Whitney (HWC) kicked off Q1 2026 with total revenue of US$279.5 million and basic EPS of US$0.58, alongside trailing twelve month revenue of US$1.4 billion and EPS of US$4.92, giving investors a fresh read on both quarterly and rolling earnings power. Over the last few reported quarters, revenue has ranged from US$351.3 million to US$375.1 million while EPS moved between roughly US$1.32 and US$1.51, so this latest print lands against a backdrop of higher trailing revenue and earnings...
NYSE:T
NYSE:TTelecom

AT&T (T) One Off US$5.3b Gain Lifts Margins And Tests Bullish Narratives

Setting the scene: AT&T’s latest numbers in focus AT&T (T) opened 2026 with Q1 revenue of US$31.5 billion and basic EPS of US$0.55, setting the tone for how its earnings story is evolving after a year of margin improvement. The company has seen quarterly revenue move from US$30.6 billion in Q1 2025 to US$31.5 billion in Q1 2026, while basic EPS shifted from US$0.61 to US$0.55 over the same period, against a trailing twelve month EPS of about US$3.01. For investors, the headline is that...
NYSE:SM
NYSE:SMOil and Gas

SM Energy (SM) Is Up 6.3% After Upgraded Earnings Outlook and Production Forecasts - Has The Bull Case Changed?

In recent days, SM Energy drew attention after Wells Fargo maintained its Equal Weight rating while projecting robust first‑quarter 2026 oil and total production volumes. At the same time, a Zacks Rank #1 (Strong Buy) based on upgraded earnings estimates and expected revenue growth has sharpened focus on SM Energy’s near‑term operating momentum. Next, we’ll examine how these upgraded earnings expectations and production forecasts interact with SM Energy’s existing investment narrative and...
NYSE:BDX
NYSE:BDXMedical Equipment

Is It Time To Reconsider Becton Dickinson (BDX) After Prolonged Share Price Weakness

If you are wondering whether Becton Dickinson shares around US$155.65 are offering value or risk right now, the key is to look closely at what the current price actually reflects. The stock has been broadly flat over the last week at 0.1% and over the last month with a 0.4% decline. Year to date it is down 20.2% and up only 0.2% over the past year. This raises questions about how expectations have shifted compared with a 19.0% decline over three years and a 14.2% decline over five...
NasdaqCM:CAAS
NasdaqCM:CAASAuto Components

China Automotive Systems (NasdaqCM:CAAS) Q4 EPS Beat Challenges Margin‑Focused Bear Narratives

China Automotive Systems FY 2025 Earnings Snapshot China Automotive Systems (NasdaqCM:CAAS) has wrapped up FY 2025 with fourth quarter revenue of US$229.2 million and basic EPS of US$0.61, capping a year where trailing twelve month revenue reached US$765.7 million and EPS came in at US$1.42, alongside earnings growth of 5.3% over the past year. The company has seen revenue move from US$188.7 million and EPS of US$0.30 in Q4 2024 to US$229.2 million and EPS of US$0.61 in Q4 2025. Meanwhile,...